European biotech firms face funding crisis March 17, 2009
One in five of Europe's biotech firms risks bankruptcy in 2009 as the credit crunch starved them of vital funding, a study by French research firm Alcimed showed on Monday.
As a result, 20 000 highly skilled science jobs could be lost. European biotech was vulnerable because most firms were still at a loss-making stage. The study found the majority of firms needed to raise funds within 18 months. - Reuters
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
